Bank of Montreal’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-35,586
Closed -$415K 3237
2024
Q4
$415K Buy
+35,586
New +$415K ﹤0.01% 2076
2024
Q2
Sell
-87,426
Closed -$2.46M 3739
2024
Q1
$2.46M Buy
+87,426
New +$2.46M ﹤0.01% 1353
2023
Q2
Sell
-7,714
Closed -$289K 3717
2023
Q1
$289K Buy
7,714
+1,270
+20% +$47.6K ﹤0.01% 2552
2022
Q4
$321K Buy
+6,444
New +$321K ﹤0.01% 2478
2022
Q3
Sell
-68,437
Closed -$3.7K 3700
2022
Q2
$3.7K Sell
68,437
-54,728
-44% -$2.96K ﹤0.01% 1319
2022
Q1
$9.08M Buy
123,165
+83,804
+213% +$6.18M ﹤0.01% 986
2021
Q4
$4.92M Sell
39,361
-3,062
-7% -$383K ﹤0.01% 1192
2021
Q3
$5.85M Buy
42,423
+40,212
+1,819% +$5.55M ﹤0.01% 1430
2021
Q2
$336K Sell
2,211
-606
-22% -$92.1K ﹤0.01% 2889
2021
Q1
$206K Sell
2,817
-5,839
-67% -$427K ﹤0.01% 2736
2020
Q4
$630K Buy
8,656
+5,964
+222% +$434K ﹤0.01% 2180
2020
Q3
$56K Sell
2,692
-1,076
-29% -$22.4K ﹤0.01% 2984
2020
Q2
$92K Buy
3,768
+3,509
+1,355% +$85.7K ﹤0.01% 2775
2020
Q1
$3K Sell
259
-4,999
-95% -$57.9K ﹤0.01% 3475
2019
Q4
$77K Buy
5,258
+1,300
+33% +$19K ﹤0.01% 3103
2019
Q3
$52K Buy
3,958
+134
+4% +$1.76K ﹤0.01% 3124
2019
Q2
$63K Buy
3,824
+3,069
+406% +$50.6K ﹤0.01% 3128
2019
Q1
$13K Buy
755
+287
+61% +$4.94K ﹤0.01% 3390
2018
Q4
$6K Sell
468
-561
-55% -$7.19K ﹤0.01% 3666
2018
Q3
$30K Sell
1,029
-7
-0.7% -$204 ﹤0.01% 3261
2018
Q2
$28K Buy
1,036
+736
+245% +$19.9K ﹤0.01% 3302
2018
Q1
$6K Sell
300
-1,000
-77% -$20K ﹤0.01% 3605
2017
Q4
$25K Sell
1,300
-4,984
-79% -$95.8K ﹤0.01% 3202
2017
Q3
$155K Sell
6,284
-1,638
-21% -$40.4K ﹤0.01% 2539
2017
Q2
$127K Buy
7,922
+7,222
+1,032% +$116K ﹤0.01% 2619
2017
Q1
$10K Sell
700
-73
-9% -$1.04K ﹤0.01% 3280
2016
Q4
$12K Buy
773
+73
+10% +$1.13K ﹤0.01% 3230
2016
Q3
$12K Buy
+700
New +$12K ﹤0.01% 3247